Pathos Communications H1 revenue rises 14% as cash receipts jump 80%

A stronger first half for Pathos

Pathos Communications has delivered double-digit growth in revenue and adjusted EBITDA during its first six months as a public company, alongside a notable improvement in cash collection.

Revenue for the six months ended 30 June 2026 is expected to reach US$7.3 million, up 14% from US$6.4 million in H1 2025.

Adjusted EBITDA is expected to increase by 31%, from US$1.3 million to US$1.7 million. This measures earnings before interest, tax, depreciation and amortisation, with further adjustments for share-based payments and certain non-recurring costs.

For investors, the quality of that growth may be as important as its pace. Cash receipts increased by 80%, repeat customers generated a much larger share of revenue and net cash came in ahead of market expectations.

H1 performance	H1 2026	H1 2025	Change
Revenue	US$7.3 million	US$6.4 million	14%
Adjusted EBITDA	US$1.7 million	US$1.3 million	31%
Adjusted EBITDA margin	23.3%	20.3%	3.0 percentage points
Revenue from repeat customers	36%	16%	20 percentage points
Cash receipts	Not disclosed	Not disclosed	80% increase

The implied adjusted EBITDA margin improved to approximately 23.3%, compared with roughly 20.3% a year earlier. That suggests profit grew faster than revenue despite investment in sales, technology and geographic expansion, as well as the introduction of public company costs from December 2025.

Cash conversion is moving in the right direction

Net cash stood at US$5.9 million on 30 June 2026, compared with US$6.2 million at the end of December 2025.

The US$0.3 million reduction looks modest given the investments made during the period. Management also said the closing position was ahead of market expectations, although the expected figure was not disclosed.

Cash receipts from customers rose by 80% year on year. Pathos attributes this to enhanced credit checks and collection processes introduced during H1 2025.

Bad debts represented approximately 4% of revenue. That remains a figure worth monitoring, particularly because Pathos serves small and micro-sized businesses, but the combination of stronger receipts and a relatively stable cash balance indicates that collection processes have improved.

Repeat business improves revenue quality

Approximately 36% of H1 revenue came from repeat customers, up from 16% in the comparable period.

This is an encouraging development. Repeat customers can provide greater revenue visibility and reduce reliance on constantly winning new business. It also suggests clients are returning to expand or renew engagements, rather than treating Pathos as a one-off service provider.

The company uses a pay-on-results model rather than the long-term subscription fees common in traditional public relations. That may make its services more accessible to smaller businesses, but it can also make revenue less predictable than a contracted recurring model. A higher proportion of repeat business should help offset some of that risk.

Pathos also highlighted its largest sale to date, a 12-month US$0.7 million contract with a major non-profit consulting firm. Delivery is ongoing, with the related revenue and adjusted EBITDA expected to be spread evenly across FY 2026 and FY 2027.

Sales investment is beginning to show results

Pathos invested in new sales managers during the half, creating more focused teams to support commercial growth.

Since the new structure was introduced, month-on-month new client sign-ups have risen by approximately 30%. The precise starting date, number of sign-ups and absolute customer figures were not disclosed, so investors should treat the percentage as an early operational indicator rather than a complete measure of sales productivity.

Geographic expansion is another part of the strategy. Pathos now serves clients across more than 80 countries and has launched a dedicated Asia-Pacific operation. Management said the early signs are positive, although no regional revenue figures were provided.

The product mix has also widened through the addition of podcast services and book publishing. Meanwhile, a new 24-month agreement with one of the three largest US news periodicals gives the publisher a commitment to publish up to 2,000 articles for Pathos clients.

Importantly, the arrangement contains no minimum commitment from Pathos. That limits its contractual obligation, although the RNS does not disclose the agreement's expected revenue or profit contribution.

Pressella could improve sales efficiency

Technology remains central to the investment case.

Initial testing of Pressella, Pathos's artificial intelligence-powered virtual publicist, indicated at least seven times the success rate of human colleagues in sales development activities. The company said that trend has continued.

Following the appointment of Scott Feltham as chief technology officer, Pathos has expanded Pressella's training and the areas of the business in which it operates. Its other proprietary tool, PathosMind, is also progressing, with both products expected to become generally available in H1 2027.

The seven-times claim is eye-catching, but supporting measures such as conversion rates, cost savings and revenue generated were not disclosed. The practical value will depend on whether Pathos can turn better sales-development performance into profitable customer growth at scale.

Pathos is also developing Generative Engine Optimisation services. GEO involves structuring content so that artificial intelligence search tools can process, summarise and cite it more easily.

Management views this as a significant commercial opportunity and cited an expectation that the development of GEO could contribute to a doubling of global PR spending by 2027. Investors will still need evidence of demand translating into contracts and revenue for Pathos itself.

What is needed in the second half?

The board remains confident of meeting FY 2026 market expectations of US$14.0 million in revenue and US$4.0 million in adjusted EBITDA.

Based on the expected first-half figures, Pathos needs approximately US$6.7 million of H2 revenue and US$2.3 million of H2 adjusted EBITDA to reach those targets.

FY 2026 expectations	H1 expected	Implied H2 requirement	Full year target
Revenue	US$7.3 million	US$6.7 million	US$14.0 million
Adjusted EBITDA	US$1.7 million	US$2.3 million	US$4.0 million

The revenue requirement is below the H1 contribution, but adjusted EBITDA must increase by around US$0.6 million between the two halves. That implies stronger second-half profitability, consistent with management's expectation that returns from H1 investments will begin to be fully realised.

This is achievable on the figures presented, but not automatic. Execution risks include converting sales momentum into collected cash, keeping bad debts under control, delivering the major contract and ensuring investment in people and technology produces an adequate return.

Pathos is also evaluating value-accretive mergers and acquisitions. No targets, timing or potential transaction values were disclosed, so this remains an optional element rather than something investors can currently model.

September's interim results should add useful detail

The update shows positive momentum across revenue, adjusted EBITDA, cash collection and repeat business. The limited decline in net cash, despite investment, is another constructive feature.

The main questions concern how durable the improved sales performance will be and whether Pathos can deliver the required step-up in second-half adjusted EBITDA. Investors will also want more detail on bad debts, customer economics, regional expansion and the measurable contribution from its artificial intelligence tools.

Pathos expects to publish its full interim results in September 2026. Those accounts should provide a clearer view of margins, cash flow and the financial impact of the growth investments made during the first half.